Filed: 5/15/2025ACC: 0001654954-25-005756
📋 What this filing means
CAMBER CAPITAL MANAGEMENT LP filed this quarterly 13F‑HR report disclosing 31 equity positions with a total reported market value of $2.81B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
31
Positions
$2.81B
Total AUM (reported)
60.75M
Total Shares
Allocation by class
COM$1.48B52.5%
TR UNIT$839.09M29.8%
S&P BIOTECH$162.20M5.8%
CL A$119.91M4.3%
SPONSORED ADR$93.29M3.3%
COM SHS$56.21M2.0%
COMMON STOCK$34.72M1.2%
Portfolio Concentration
Top 3$1.33B47.2%
4–10$937.03M33.3%
11–25$514.72M18.3%
Rest$33.82M1.2%
Top 3 weight
47.2%
Top 10 weight
80.5%
Voting Authority Distribution
Total shares with voting rights: 60.75M
Sole
Full voting authority
60.75M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole31
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings31
Rows:
SPDR S&P 500 ETF TR
SOLEShares1.50M
TypeSH
Market value$839.09M
29.81%
Sole
1.50M
Shared
0.00
None
0.00
ZIMMER BIOMET HOLDINGS INC
SOLEShares2.25M
TypeSH
Market value$254.66M
9.05%
Sole
2.25M
Shared
0.00
None
0.00
PFIZER INC
SOLEShares9.30M
TypeSH
Market value$235.66M
8.37%
Sole
9.30M
Shared
0.00
None
0.00
BAXTER INTL INC
SOLEShares5.75M
TypeSH
Market value$196.82M
6.99%
Sole
5.75M
Shared
0.00
None
0.00
HUMANA INC
SOLEShares725K
TypeSH
Market value$191.84M
6.81%
Sole
725K
Shared
0.00
None
0.00
SPDR SER TR
SOLEShares2M
TypeSH
Market value$162.20M
5.76%
Sole
2M
Shared
0.00
None
0.00
CVS HEALTH CORP
SOLEShares2.25M
TypeSH
Market value$152.44M
5.42%
Sole
2.25M
Shared
0.00
None
0.00
GLOBUS MED INC
SOLEShares1.25M
TypeSH
Market value$91.50M
3.25%
Sole
1.25M
Shared
0.00
None
0.00
PTC THERAPEUTICS INC
SOLEShares1.50M
TypeSH
Market value$76.44M
2.72%
Sole
1.50M
Shared
0.00
None
0.00
THE CIGNA GROUP
SOLEShares200K
TypeSH
Market value$65.80M
2.34%
Sole
200K
Shared
0.00
None
0.00
VIATRIS INC
SOLEShares7.50M
TypeSH
Market value$65.33M
2.32%
Sole
7.50M
Shared
0.00
None
0.00
QIAGEN NV
SOLEShares1.40M
TypeSH
Market value$56.21M
2.00%
Sole
1.40M
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares350K
TypeSH
Market value$54.55M
1.94%
Sole
350K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares800K
TypeSH
Market value$51.06M
1.81%
Sole
800K
Shared
0.00
None
0.00
BROOKDALE SR LIVING INC
SOLEShares6.25M
TypeSH
Market value$39.13M
1.39%
Sole
6.25M
Shared
0.00
None
0.00
GSK PLC
SOLEShares1M
TypeSH
Market value$38.74M
1.38%
Sole
1M
Shared
0.00
None
0.00
BIOMARIN PHARMACEUTICAL INC
SOLEShares500K
TypeSH
Market value$35.34M
1.26%
Sole
500K
Shared
0.00
None
0.00
CONCENTRA GROUP HOLDINGS PAR
SOLEShares1.60M
TypeSH
Market value$34.72M
1.23%
Sole
1.60M
Shared
0.00
None
0.00
EVOLENT HEALTH INC
SOLEShares3M
TypeSH
Market value$28.41M
1.01%
Sole
3M
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares725K
TypeSH
Market value$21.87M
0.78%
Sole
725K
Shared
0.00
None
0.00
MYRIAD GENETICS INC
SOLEShares2.35M
TypeSH
Market value$20.84M
0.74%
Sole
2.35M
Shared
0.00
None
0.00
ZIMVIE INC
SOLEShares1.89M
TypeSH
Market value$20.36M
0.72%
Sole
1.89M
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares441K
TypeSH
Market value$17.23M
0.61%
Sole
441K
Shared
0.00
None
0.00
DENALI THERAPEUTICS INC
SOLEShares1.25M
TypeSH
Market value$16.99M
0.60%
Sole
1.25M
Shared
0.00
None
0.00
ANAPTYSBIO INC
SOLEShares750K
TypeSH
Market value$13.94M
0.50%
Sole
750K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P 500 ETF TRSOLE | TR UNIT | 1.50M | SH | $839.09M 29.81% | 1.50M | 0.00 | 0.00 |
ZIMMER BIOMET HOLDINGS INCSOLE | COM | 2.25M | SH | $254.66M 9.05% | 2.25M | 0.00 | 0.00 |
PFIZER INCSOLE | COM | 9.30M | SH | $235.66M 8.37% | 9.30M | 0.00 | 0.00 |
BAXTER INTL INCSOLE | COM | 5.75M | SH | $196.82M 6.99% | 5.75M | 0.00 | 0.00 |
HUMANA INCSOLE | COM | 725K | SH | $191.84M 6.81% | 725K | 0.00 | 0.00 |
SPDR SER TRSOLE | S&P BIOTECH | 2M | SH | $162.20M 5.76% | 2M | 0.00 | 0.00 |
CVS HEALTH CORPSOLE | COM | 2.25M | SH | $152.44M 5.42% | 2.25M | 0.00 | 0.00 |
GLOBUS MED INCSOLE | CL A | 1.25M | SH | $91.50M 3.25% | 1.25M | 0.00 | 0.00 |
PTC THERAPEUTICS INCSOLE | COM | 1.50M | SH | $76.44M 2.72% | 1.50M | 0.00 | 0.00 |
THE CIGNA GROUPSOLE | COM | 200K | SH | $65.80M 2.34% | 200K | 0.00 | 0.00 |
VIATRIS INCSOLE | COM | 7.50M | SH | $65.33M 2.32% | 7.50M | 0.00 | 0.00 |
QIAGEN NVSOLE | COM SHS | 1.40M | SH | $56.21M 2.00% | 1.40M | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 350K | SH | $54.55M 1.94% | 350K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 800K | SH | $51.06M 1.81% | 800K | 0.00 | 0.00 |
BROOKDALE SR LIVING INCSOLE | COM | 6.25M | SH | $39.13M 1.39% | 6.25M | 0.00 | 0.00 |
GSK PLCSOLE | SPONSORED ADR | 1M | SH | $38.74M 1.38% | 1M | 0.00 | 0.00 |
BIOMARIN PHARMACEUTICAL INCSOLE | COM | 500K | SH | $35.34M 1.26% | 500K | 0.00 | 0.00 |
CONCENTRA GROUP HOLDINGS PARSOLE | COMMON STOCK | 1.60M | SH | $34.72M 1.23% | 1.60M | 0.00 | 0.00 |
EVOLENT HEALTH INCSOLE | CL A | 3M | SH | $28.41M 1.01% | 3M | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | COM | 725K | SH | $21.87M 0.78% | 725K | 0.00 | 0.00 |
MYRIAD GENETICS INCSOLE | COM | 2.35M | SH | $20.84M 0.74% | 2.35M | 0.00 | 0.00 |
ZIMVIE INCSOLE | COM | 1.89M | SH | $20.36M 0.72% | 1.89M | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 441K | SH | $17.23M 0.61% | 441K | 0.00 | 0.00 |
DENALI THERAPEUTICS INCSOLE | COM | 1.25M | SH | $16.99M 0.60% | 1.25M | 0.00 | 0.00 |
ANAPTYSBIO INCSOLE | COM | 750K | SH | $13.94M 0.50% | 750K | 0.00 | 0.00 |
Page 1 of 2